Aug 26, 2025 | Elections, JoCo Spending, Kansas Issues, Property Taxes, Public Safety, Safety, Taxes, Transparency, Voting
By: Charlotte O’Hara Oh, this is a doozy!!! Kansas, hold on to your billfolds and pocketbooks! Last Thursday, August 21st, the De Soto City Council approved a development agreement with Mount Sunflower Properties, LLC (formed in Delaware in 2024) for an...
Aug 19, 2025 | Elections, JoCo Spending, Kansas Issues, Property Taxes, Taxes, Transparency, Voting
By: Charlotte O’Hara Ah, Johnson County—the engine of Kansas’ economic prosperity. Beautiful suburbs, lush lawns, and schools flush with funding have long been the image. But behind this oasis lies a 40-year heist: economic development schemes, tax...
Aug 12, 2025 | Elections, JoCo Spending, Kansas Issues, Transparency, Voting
By: Charlotte O’Hara Well, This Is Rich! The Johnson County Board of County Commissioners (JoCo BOCC), under the leadership of Chairman Mike Kelly, decided it was necessary to hire a consultant, HAYSTAQDNA, to assist with redistricting the six commission...
Aug 5, 2025 | Elections, Kansas Issues, Property Taxes, Taxes, Transparency, Voting
By: Charlotte O’Hara For years, I have sounded the alarm on tax incentives decimating Kansas’ tax base. More recently in 2022 I fought the ill-advised Attracting Powerful Economic Expansion (APEX) bill which gave Panasonic $829 million in state tax...
Jul 29, 2025 | Elections, JoCo Spending, Kansas Issues, Taxes, Transparency, Voting
By: Charlotte O’Hara Well, the Johnson County Commission — led by Chairman Mike Kelly (an attorney) — got a serious slap down from Attorney General Kris Kobach on Tuesday, July 22. The AG’s office issued a legal opinion declaring that the 1/4 cent public...
Jul 22, 2025 | Elections, Kansas Issues, Public Safety, Safety, Transparency, Voting
By: Charlotte O’Hara First, let me be clear: I’m not a doctor. I’m simply reporting on the politics surrounding the human use of Ivermectin. What’s unfolding is a fascinating and high-stakes battle between the FDA and Big Pharma on one side, and doctors...
